A Placebo-Controlled Trial of Bezafibrate in Primary Biliary CholangitisChristophe Corpechot, Raoul Poupon, Odile Goria et al.|New England Journal of Medicine|2018Cited by 605
Extrahepatic autoimmune diseases in primary biliary cholangitis: Prevalence and significance for clinical presentation and disease outcomeCumali Efe, Staffan Wåhlin, Murat Torğutalp et al.|Journal of Gastroenterology and Hepatology|2020Cited by 68
Validation of Risk Scoring Systems in Ursodeoxycholic Acid–Treated Patients With Primary Biliary CholangitisCumali Efe, Staffan Wåhlin, Koray Taşçılar et al.|The American Journal of Gastroenterology|2019Cited by 48